2001
DOI: 10.1007/s004670100631
|View full text |Cite
|
Sign up to set email alerts
|

Update on endothelins - biology and clinical implications

Abstract: In the decade since the initial discovery and characterization of endothelin, its biology as a powerful vasoconstrictor has been dramatically demonstrated. Studies have clarified the existence of endothelin isoforms, complex mechanisms of biosynthesis, interaction with specific receptors, and pathogenic implications. We are on the brink of using endothelin antagonism as a clinical treatment for disease processes where endothelin plays an important role, including congestive heart failure and hypertension. Nove… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
31
2
5

Year Published

2003
2003
2016
2016

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(38 citation statements)
references
References 80 publications
0
31
2
5
Order By: Relevance
“…2,29,[33][34][35][36][37][38][39][40][41][42] These injury-promoting GPCR systems are found in podocytes 2,29 and, thus, may contribute to podocyte injury in disease states, perhaps by upregulating COX2 expression. In this regard, endothelin 1 induces COX2 expression in glomerular mesangial cells by activating NFAT transcription factors.…”
Section: Discussionmentioning
confidence: 99%
“…2,29,[33][34][35][36][37][38][39][40][41][42] These injury-promoting GPCR systems are found in podocytes 2,29 and, thus, may contribute to podocyte injury in disease states, perhaps by upregulating COX2 expression. In this regard, endothelin 1 induces COX2 expression in glomerular mesangial cells by activating NFAT transcription factors.…”
Section: Discussionmentioning
confidence: 99%
“…Common to these GPCR systems is activation of PLC through G␣q (13)(14)(15)(16)(17)(18). To determine whether G␣q plays a key role in progression of glomerular diseases, we expressed a constitutively active G␣q in glomerular podocytes using the mouse nephrin promoter (29,30).…”
Section: Discussionmentioning
confidence: 99%
“…These injury-promoting GPCR systems are found in podocytes (2) and, thus, may contribute to podocyte injury in disease states. Although the signaling pathways that are activated by these GPCR are diverse (13)(14)(15)(16)(17)(18), common to all of these receptor systems is activation of phospholipase C (PLC) through G␣q (13)(14)(15)(16)(17)(18). Activation of PLC generates the second messengers diacyl glycerol (DAG) and inositol phosphates (IP).…”
mentioning
confidence: 99%
“…Although the signaling pathways that are activated by these GPCR are diverse, common to all of these receptor systems is activation of PLC␤ through G proteins that belong to the Gq family (71,72,(77)(78)(79)(80). Although the precise mechanisms are incompletely understood, Gq-coupled receptors are potent activators of TRPC6 (4,31,35,62,81).…”
Section: Plc-coupled Receptors On Podocytesmentioning
confidence: 99%